OncoSenX

📍 Seattle, United States👥 9 employees💰 Last funded Oct 2021
Biotechnology Research🌐 oncosenx.com
Website LinkedIn
OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA. The next generation in cancer therapies will be more targeted with less side effects. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our treatment delivers a simple program that induces apoptosis in cancerous cells. Our approach is a less invasive, more precise intervention for this complex and devastating disease.
5
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
5
Investor activity2019–2021 · investors recorded per year
2019420211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in OncoSenX?
OncoSenX has 5 investors on record on gritt.io.
When did OncoSenX last raise funding?
The most recent investment in OncoSenX recorded on gritt.io was in October 2021.
What industry is OncoSenX in?
OncoSenX operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is OncoSenX based?
OncoSenX is headquartered in Seattle, United States.